Cargando…
Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis
An 18-year-old man diagnosed with ileocolonic Crohn's disease with circumferential strictures of the ascending colon started treatment with mesalazine and subsequently underwent right hemicolectomy. After surgery, the patient was started on adalimumab, and the clinical course was favorable. Nin...
Autores principales: | Tsuboi, Rumiko, Matsumoto, Satohiro, Miyatani, Hiroyuki, Mashima, Hirosato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443567/ https://www.ncbi.nlm.nih.gov/pubmed/30333413 http://dx.doi.org/10.2169/internalmedicine.1607-18 |
Ejemplares similares
-
Efficacy of Combined Mesalazine Plus Corticosteroid Enemas for Diversion Colitis after Subtotal Colectomy for Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2016) -
Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
por: Matsumoto, Satohiro, et al.
Publicado: (2020) -
Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases
por: Kawamura, Haruna, et al.
Publicado: (2017) -
Real-World Long-Term Remission Maintenance for 10 Years With Thiopurines in Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2021) -
Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort study
por: Matsumoto, Satohiro, et al.
Publicado: (2017)